Moderna is testing out its potential COVID-19 vaccine boosters for protection from emerging coronavirus variants. The vaccine maker announced that part of its phase two study has begun, and 60 participants who were already vaccinated with Moderna’s original COVID-19 vaccine will be given a booster of its modified vaccines.
Right now, the three COVID-19 vaccines on the U.S. market are for adults. You must be 18 or older to get Moderna and Johnson & Johnson vaccines, and 16 or older for the vaccine made by Pfizer. Clinical trials are now underway for younger children.
Officials with the South Carolina Department of Health and Environmental Control provided an update on the vaccine distribution efforts in the state.
COVID-19 vaccine makers tell Congress to expect a big jump in the delivery of doses over the coming month.
Colonial Life Arena transformed Monday to host and vaccinate more than one-thousand local veterans, thanks to a partnership between the Columbia VA Health Care System and the University of South Carolina.
Prisma Health announced that it delivered its 100,000th dose of the coronavirus vaccine on Monday.
Moderna says 30 million doses have been delivered in the U.S., but less than half have been administered
Moderna says they have supplied 30 million vaccine doses across the country so far. That’s an additional 12.4 million doses since January 4, when the company last gave a supply update.
The Moderna vaccine appears to give people at least a year’s worth of protection from COVID-19, according to Tal Zaks, the company’s Chief Medical Officer.
The Food Drug Administration is meeting this week to consider giving half doses of Moderna’s COVID-19 vaccine to people ages 18-55.
Vice President-elect Kamala Harris received her Moderna coronavirus vaccination on Tuesday.